Achillion Announces 100% SVR Reported in Janssen’s Phase 2a Trial Evaluating Triple Combination of Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Naive HCV

- New data released today in abstract for upcoming EASL / AASLD Special Conference: New Perspectives in Hepatitis C Virus Infection – The Roadmap For Cure - - Janssen advancing triple combination into Phase 2b clinical trial - NEW HAVEN, Conn., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today that new interim results from a p … [Read more...]

Advanced Emissions Solutions to Present at Rodman & Renshaw Investor Conference

HIGHLANDS RANCH, Colo., Sept. 08, 2016 (GLOBE NEWSWIRE) -- Advanced Emissions Solutions, Inc. (NASDAQ:ADES) (the "Company" or "ADES") today announced that the Company will be presenting at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City at 12:05 p.m. ET on Tuesday, September 13, 2016. The Company will provide an overview of the Company’s b … [Read more...]

S-BIO Launches EZGlyco™ mAb-N Kit with 2-AB for N-Glycan Sample Preparation

HUDSON, N.H., Sept. 08, 2016 (GLOBE NEWSWIRE) -- S-BIO1 has launched today EZGlycoTM mAb-N Kit with 2-AB, a breakthrough new product that enables scientists to analyze N-glycans in IgG and Fc-fusion proteins from culture supernatant samples in a rapid, simplified and streamlined single tube operation. The kit is a valuable tool supporting customers in glycoprotein … [Read more...]

Six Expert Regulatory Professionals to be Honored as RAPS Fellows

ROCKVILLE, MD., Sept. 8, 2016 (GLOBE NEWSWIRE) -- The Regulatory Affairs Professionals Society (RAPS) today announced six regulatory experts have joined the elite ranks of RAPS Fellows. The 2016 Fellows will be honored Tuesday, 20 September, during RAPS' Regulatory Convergence conference in San Jose, CA. The Convergence is the largest annual gathering of the global regulatory … [Read more...]

Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Closing Bell

ADVISORY, Sept. 08, 2016 (GLOBE NEWSWIRE) -- What: Celgene Corporation (Nasdaq:CELG), an integrated global biopharmaceutical company, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Mark J. Alles, Chief Executive Officer, will ring the Closing Bell.  Where:Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio Whe … [Read more...]